Partnerships for the Development of Host-Targeted Therapeutics to Limit Antimicrobial Resistance (R01)
The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications for milestone-driven projects focused on preclinical development of candidate therapeutics that target host-encoded functions required for infection, replication, virulence, proliferation and/or pathogenesis of select bacterial pathogens for which drug resistance poses a significant public health concern.
General information about this opportunity
Last Known Status
Deleted 10/18/2015 (Archived.)
Program Number
RFA-AI-15-024 Federal Agency/Office
Agency: Department of Health and Human ServicesOffice: National Institutes of Health
Type(s) of Assistance Offered
Grant Who is eligible to apply/benefit from this assistance?
Applicant Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. What is the process for applying and being award this assistance?
Deadlines
09/17/2015 Other Assistance Considerations
Formula and Matching Requirements
This program does not have cost sharing or matching requirements. Who do I contact about this opportunity?
Headquarters Office
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
Website Address
http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-15-024.html
E-mail Address
FBOWebmaster@OD.NIH.GOV
Financial Information
Obligations
$11,500,000.00
